Financial Health Check: Examining Ventyx Biosciences Inc (VTYX)’s Key Ratios

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Ventyx Biosciences Inc (NASDAQ: VTYX) closed the day trading at $2.10 up 1.94% from the previous closing price of $2.06. In other words, the price has increased by $1.94 from its previous closing price. On the day, 0.58 million shares were traded. VTYX stock price reached its highest trading level at $2.14 during the session, while it also had its lowest trading level at $2.06.

Ratios:

For a better understanding of VTYX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.19 and its Current Ratio is at 14.19. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on March 12, 2024, Upgraded its rating to Overweight and sets its target price to $16 from $7 previously.

On March 12, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $12.

Wells Fargo Downgraded its Overweight to Equal Weight on November 07, 2023, whereas the target price for the stock was revised from $77 to $8.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’24 when Krueger Christopher W sold 1,651 shares for $5.40 per share. The transaction valued at 8,921 led to the insider holds 284,999 shares of the business.

Nuss John sold 1,651 shares of VTYX for $8,921 on Apr 02 ’24. The CHIEF SCIENTIFIC OFFICER now owns 264,998 shares after completing the transaction at $5.40 per share. On Apr 02 ’24, another insider, Mohan Raju, who serves as the CEO AND PRESIDENT of the company, sold 4,312 shares for $5.40 each. As a result, the insider received 23,299 and left with 1,578,250 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTYX now has a Market Capitalization of 148405104 and an Enterprise Value of -79767824.

Stock Price History:

Over the past 52 weeks, VTYX has reached a high of $30.67, while it has fallen to a 52-week low of $1.79. The 50-Day Moving Average of the stock is -4.27%, while the 200-Day Moving Average is calculated to be -41.24%.

Shares Statistics:

Over the past 3-months, VTYX traded about 1.24M shares per day on average, while over the past 10 days, VTYX traded about 2555570 shares per day. A total of 59.24M shares are outstanding, with a floating share count of 54.69M. Insiders hold about 22.62% of the company’s shares, while institutions hold 71.85% stake in the company. Shares short for VTYX as of 1726185600 were 8603382 with a Short Ratio of 6.92, compared to 1723680000 on 9335315. Therefore, it implies a Short% of Shares Outstanding of 8603382 and a Short% of Float of 14.249999999999998.

Most Popular